Kas diabeetikutel on võid?

Dipeptidyl peptidase‐4 inhibitors (DPP‐4i) are a common first‐line treatment for type 2 diabetes in Japan. However, little is known about patients’ medication adherence, persistence and discontinuation in this setting. The final sample contained 2,874 monotherapy and 3,016 dual therapy.Kas on võimalik 2. tüüpi diabeediga mett või mitte? Kuna see toode on organismist kergesti